| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aileron Therapeutics, Inc. | President and CEO | Common Stock | 7,122 | $16,025 | $2.25 | 05 Dec 2024 | Direct |
| Aileron Therapeutics, Inc. | President and CEO | Common Stock | 161 | $362 | $2.25 | 05 Dec 2024 | By son |
| Aileron Therapeutics, Inc. | President and CEO | Stock Option (right to buy) | 517,500 | 02 Dec 2024 | Direct | ||
| AILERON THERAPEUTICS INC | President and CEO | Series X Non-Voting Convertible Preferred | 0 | 05 Mar 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RNTX | Aileron Therapeutics, Inc. | 05 Dec 2024 | 2 | +$898 | 4 | President and CEO | 09 Dec 2024, 16:09 |
| RNTX | Aileron Therapeutics, Inc. | 02 Dec 2024 | 1 | $0 | 4 | President and CEO | 04 Dec 2024, 16:05 |
| RNTX | AILERON THERAPEUTICS INC | 05 Mar 2024 | 2 | $0 | 4 | President and COO | 06 Mar 2024, 17:06 |
| RNTX | AILERON THERAPEUTICS INC | 15 Dec 2023 | 1 | +$758 | 4 | President and COO | 18 Dec 2023, 17:56 |
| RNTX | AILERON THERAPEUTICS INC | 20 Nov 2023 | 1 | +$9,987 | 4 | President and COO | 21 Nov 2023, 16:43 |
| RNTX | AILERON THERAPEUTICS INC | 31 Oct 2023 | 0 | $0 | 3 | Exhibit 24.1 Power of Attorney President and Chief Operating Officer | 02 Nov 2023, 20:47 |